|Articles|August 29, 2019
High-touch services that enhance patient outcomes
Author(s)McKesson Life Sciences
In today’s evolving, value-based environment for specialty drugs, high-touch services that enhance patient outcomes are playing an increasingly important role in market access and patient care delivery. Using gene therapy as a specific example, this white paper will discuss many of the high-touch services that can help enhance patient outcomes.
Related Content
Trending on PharmExec
1
Nuvation Bio’s Approach to Building a Compelling Narrative
2
Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform
3
Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals
4
Nuvation Bio’s Global Strategy
5